Mosaic Family Wealth LLC Has $838,000 Holdings in Colgate-Palmolive Company (CL)
Mosaic Family Wealth LLC lowered its position in Colgate-Palmolive Company (NYSE:CL) by 0.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 11,307 shares of the company’s stock after selling 63 shares during the period. Mosaic Family Wealth LLC’s holdings in Colgate-Palmolive were worth $838,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Waldron LP bought a new stake in shares of Colgate-Palmolive during the first quarter valued at approximately $238,000. Community Bank N.A. raised its stake in shares of Colgate-Palmolive by 2.0% during the first quarter. Community Bank N.A. now owns 13,776 shares of the company’s stock valued at $1,008,000 after acquiring an additional 270 shares in the last quarter. Carl Domino Inc raised its stake in shares of Colgate-Palmolive by 2.9% during the first quarter. Carl Domino Inc now owns 15,819 shares of the company’s stock valued at $1,158,000 after acquiring an additional 449 shares in the last quarter. TIAA CREF Trust Co. FSB MO raised its stake in shares of Colgate-Palmolive by 2.9% during the first quarter. TIAA CREF Trust Co. FSB MO now owns 86,652 shares of the company’s stock valued at $6,342,000 after acquiring an additional 2,423 shares in the last quarter. Finally, Henderson Group PLC raised its stake in shares of Colgate-Palmolive by 8.5% during the first quarter. Henderson Group PLC now owns 440,631 shares of the company’s stock valued at $32,252,000 after acquiring an additional 34,661 shares in the last quarter. 73.09% of the stock is owned by institutional investors and hedge funds.
CL has been the subject of several research analyst reports. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price target for the company in a research note on Tuesday, July 4th. Jefferies Group LLC reaffirmed a “hold” rating and set a $79.00 price target on shares of Colgate-Palmolive in a research note on Thursday, September 28th. KeyCorp reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research note on Monday, October 16th. Macquarie initiated coverage on shares of Colgate-Palmolive in a research note on Thursday, September 14th. They set a “neutral” rating and a $76.00 price target for the company. Finally, Wells Fargo & Company reaffirmed a “market perform” rating on shares of Colgate-Palmolive in a research note on Monday, July 24th. One equities research analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and four have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $76.85.
In other Colgate-Palmolive news, insider Patricia Verduin sold 3,833 shares of the firm’s stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $71.45, for a total transaction of $273,867.85. Following the transaction, the insider now directly owns 53,173 shares of the company’s stock, valued at approximately $3,799,210.85. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Justin Skala sold 74,374 shares of the firm’s stock in a transaction on Thursday, July 27th. The stock was sold at an average price of $72.51, for a total transaction of $5,392,858.74. Following the transaction, the chief operating officer now directly owns 97,177 shares in the company, valued at $7,046,304.27. The disclosure for this sale can be found here. Insiders sold a total of 214,136 shares of company stock worth $15,416,385 over the last ninety days. Insiders own 1.02% of the company’s stock.
Shares of Colgate-Palmolive Company (NYSE:CL) opened at 72.32 on Monday. The stock’s 50 day moving average is $72.83 and its 200 day moving average is $73.22. The firm has a market capitalization of $63.70 billion, a P/E ratio of 26.87 and a beta of 0.81. Colgate-Palmolive Company has a 1-year low of $63.43 and a 1-year high of $77.27.
Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, July 21st. The company reported $0.72 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.72. The firm had revenue of $3.83 billion for the quarter, compared to the consensus estimate of $3.89 billion. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. The company’s revenue was down .5% on a year-over-year basis. During the same period last year, the firm posted $0.70 EPS. Equities analysts predict that Colgate-Palmolive Company will post $2.90 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, November 15th. Investors of record on Monday, October 23rd will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.21%. The ex-dividend date of this dividend is Friday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is 59.48%.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.